Safety evaluation of a recombinant myxoma-RHDV virus inducing horizontal transmissible protection against myxomatosis and rabbit haemorrhagic disease

Vaccine

Volumn 19, Issue 2-3, 2000, Pages 174-182

  Torres, Juan M ^a   Ramírez, Miguel A ^a   Morales, Mónica ^a   Bárcena, Juan ^a   Vázquez, Belén ^a   Espuña, Enric ^b   Pagès Manté, Albert ^b   Sánchez Vizcaíno, José M ^a  

^a Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria   (Spain)

^b LABORATORIOS HIPRA S A   (Spain)

Author keywords

Myxoma RHDV; Safety; Transmissible vaccine

Indexed keywords

ANIMAL DISEASE; ANIMAL MODEL; ARTICLE; IMMUNIZATION; MYXOMATOSIS; NONHUMAN; PRIORITY JOURNAL; RABBIT; VIRUS RECOMBINANT; VIRUS TRANSMISSION;

EID: 0343526739     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00183-3     Document Type: Article

References (32)

1. Murphy, FA, Fauquet, CM, Bishop, DHL, Ghabrial, SA, Jarvis, AW, Martelli, GP, Mayo, MA, Summers, MD., Virus taxonomy: classification and nomenclature of viruses. Sixth report of the International Commitee for the Taxonomy of Viruses. Arch. Virol. 1995;10(Supplement):586 pp. Vienna, Springer-Verlag.
2. Fenner F., Ross J. Myxomatosis. Thompson H.V., King C.M. The European rabbit. The history and biology of a successful coloniser. 1994;205-240 Oxford University Press, Oxford.
3. Kerr P.j, Best S.M. Myxoma virus in rabbits. Rev. Sci. Tech. Off. Int. Epiz. 17:1998;256-268.
4. Fenner F., Woodroofe G.M. Protection of laboratory rabbits against myxomatosis by vaccination with fibroma virus. Aust. J. exp. Biol. Med. Sci. 32:1954;653.
5. Saurat P., Gilbert Y., Ganière J.P. Etude d'une souche de virus myxomateux modifie. Rev. Med. Vet. 129:1978;415-451.
6. Liu S.J., Xue H.P., Pu B.Q., Qian S.H. A new viral disease in rabbits. Anim. Husb. Vet. Med. 16:1984;253-255.
7. Morise J.P., Le Gall G., Boilleot E. Hepatitis of viral origin in leporidae: introduction and aetiological hypotheses. Rev. Sci. Tech. Off. Int. Epiz. 10:1991;283-295.
8. Ohlinger V.F., Thiel H.J. Rabbit haemorrhagic disease (RHD): characterization of the causative calicivirus. Vet. Res. 24:1993;103-116.
9. Villafuerte R., Calvete C., Blanco J.C., Lucientes J. Incidence of viral haemorrhagic disease in wild rabbit populations in Spain. Mammalia. 59:1995;651-659.
10. Chasey D. Rabbit haemorrhagic disease: the new scourge of Oryctolagus cuniculus. Lab. Anim. 31:1997;33-44.
11. Marchandeau S., Chantal J., Portejoie Y., Barraud S., Chaval Y. Impact of viral haemorrhagic disease on a wild population of European rabbits in France. J. Wildl. Dis. 34:1998;429-435.
12. Mutze G., Cooke B., Alexander P. The initial impact of rabbit haemorrhagic disease on European rabbit populations in South Australia. J. Wildl. Dis. 34:1998;221-227.
13. Pringle C.R. Virus taxonomy - San Diego. Arch. Virol. 143:1998;1449-1459.
14. Argüello J.L. Viral haemorrhagic disease of rabbits: vaccination and immune response. Rev. Sci. Tech. Off. Int. Epiz. 10:1991;471-480.
15. Boga J.A., Casais R., Marín M.S., Martín-Alonso J.M., Cármenes R.S., Prieto M., Parra F. Molecular cloning, sequencing and expression in Escherichia coli of the capsid protein gene from rabbit haemorrhagic disease virus (Spanish isolate AST/89). J. Gen. Virol. 75:1994;2409-2413.
16. Laurent S., Vautherot J.F, Madelaine M.F., Le Gall G., Rasschaert D. Recombinant rabbit haemorrhagic disease virus capsid protein expressed in baculovirus self-assembles into viruslike particles and induces protection. J. Virol. 68:1994;6794-6798.
17. Plana-Duran J., Bastons M., Rodriguez M.J., Climent I., Cortés E., Vela C., Casal I. Oral immunization of rabbits with VP60 particles confers protection against rabbit haemorrhagic disease. Arch. Virol. 141:1996;1423-1436.
18. Sibilia M., Boniotti M.B., Angoscini P., Capucci L., Rossi C. Two independent pathways of expression lead to self-assembly of the rabbit haemorrhagic disease virus capsid protein. J. Virol. 69:1995;5812-5815.
19. Bertagnoli S., Gelfi J., Petit F., Vautherot J.F., Rasschaert D., Laurent S., Gall G., Boilletot E., Chantal J., Boucraut-Baralon C. Protection of rabbits against rabbit viral haemorrhagic disease with a vaccinia-RHDV recombinant virus. Vaccine. 14:1996;506-510.
20. Bertagnoli S., Gelfi J., Gall G., Boilletot E., Vautherot J.F., Rasschaert D., Laurent S., Petit F., Boucraut-Baralon C., Milon A. Protection against myxomatosis and rabbit viral haemorrhagic disease with recombinant myxoma viruses expressing rabbit haemorrhagic disease virus capsid protein. J. Virol. 70:1996;5061-5066.
21. Fischer L., Le Gros F.X., Mason P.W., Paoletti E. A recombinant canarypox virus protects rabbits against a lethal rabbit haemorrhagic disease virus (RHDV) challenge. Vaccine. 15:1997;90-96.
22. Boga J.A., Martín-Alonso J.M., Casais R., Parra F. A single dose immunization with rabbit haemorrhagic disease virus major capsid protein produced in Saccharomyces cerevisiae induces protection. J. Gen. Virol. 78:1997;2315-2318.
23. Castañón S., Marín M.S., Martín-Alonso J.M., Boga J.A., Casais R., Humara J.M., Ordás R.J., Parra F. Immunization with potato plants expressing VP60 protein protects against rabbit haemorrhagic disease virus. J. Virol. 73:1999;4452-4455.
24. Bárcena J., Pagès-Manté A., March R., Morales M., Ramírez M.A., Sánchez-Vizcaíno J.M., Torres J.M. Isolation of an attenuated myxoma virus field strain that confers horizontal transmissible protection against myxomatosis on contacts of vaccinates. Arch. Virol. 146:2000;759-771.
25. Bárcena J., Morales M., Vázquez B., Boga J.A., Parra F., Lucientes J., Pagès-Manté A., Sánchez-Vizcaíno J.M., Blasco R., Torres J.M. Horizontal transmissible protection against myxomatosis and rabbit haemorrhagic disease using a recombinant myxoma virus. J. Virol. 74:2000;1114-1123.
26. Brochier B., Aubert M.F., Pastoret P.P., Masson E., Schon J., Lombard M., Chappuis G., Languet B., Desmettre P. Field use of a vaccinia-rabies recombinant vaccine for the control of sylvatic rabies in Europe and North America. Rev Sci Tech. Off. Int. Epiz. 15:1996;947-970.
27. Jackson R.J., Hall D.F., Kerr P.J. Construction of recombinant myxoma viruses expressing foreign genes from different intergenic sites without associated attenuation. J. Gen. Virol. 77:1996;1569-1575.
28. Falkner F.G., Moss B. Transient dominant selection of recombinant vaccinia viruses. J.Virol. 64:1990;3108-3111.
29. Oehling A., Crisci C.D., Sanz M.L., Subira M.L. Immunosuppressive effect of corticosteroids on rabbit's humoral and cellular response. Allergol Immunopathol (Madr). 4:1976;255-268.
30. Argüello J.L. Contribución a la profilaxis de la mixomatosis del conejo mediante el uso de una cepa homóloga. Medicina Veterinaria. 3:1986;91-103.
31. Ciuchini F., Pestalozza S., Buonavoglia C., Di Trani L., Tollis M., Orfei Z. Effects of corticosteroids mediated immunosuppression on the distribution of rabies vaccine virus in red foxes orally immunized against rabies. J. Vet. Med. B. 3:1986;628-631.
32. Pedersen N.C. Immunogenicity and efficacy of a commercial feline leukemia virus vaccine. J Vet Intern Med. 7:1993;34-39.